QT Prolongation and Torsades de Pointes Associated with Clarithromycin
- 1 April 1998
- journal article
- case report
- Published by Elsevier in The American Journal of Medicine
- Vol. 104 (4) , 395-396
- https://doi.org/10.1016/s0002-9343(98)00059-x
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Torsades de pointes in two chronic renal failure patients treated with Cisapride and ClarithromycinAmerican Journal of Kidney Diseases, 1997
- Electrophysiologic Mechanisms of the Long QT Interval Syndromes and Torsade de PointesAnnals of Internal Medicine, 1995
- Torsades de Pointes Induced by ErythromycinChest, 1994
- Electrophysiological mechanisms in a canine model of erythromycin-associated long QT syndrome.Circulation, 1993
- Single‐ and Multiple‐dose Pharmacokinetics of Clarithromycin, a New Macrolide AntimicrobialThe Journal of Clinical Pharmacology, 1993
- Erythromycin-induced long QT syndrome: Concordance with quinidine and underlying cellular electrophysiologic mechanismThe American Journal of Medicine, 1990
- Association of intravenous erythromycin and potentially fatal ventricular tachycardia with Q-T prolongation (torsades de pointes).BMJ, 1990
- Effect of erythromycin on ventricular arrhythmias and ventricular repolarization in idiopathic long QT syndromeThe American Journal of Cardiology, 1987
- Recurrent ventricular tachycardia associated with QT prolongation after mitral valve replacement and its association with intravenous administration of erythromycinThe American Journal of Cardiology, 1984